88 related articles for article (PubMed ID: 22316484)
1. Antibodies against B7-DC with differential binding properties exert opposite effects.
Ritprajak P; Hashiguchi M; Akiba H; Yagita H; Okumura K; Azuma M
Hybridoma (Larchmt); 2012 Feb; 31(1):40-7. PubMed ID: 22316484
[TBL] [Abstract][Full Text] [Related]
2. Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses.
Tsushima F; Iwai H; Otsuki N; Abe M; Hirose S; Yamazaki T; Akiba H; Yagita H; Takahashi Y; Omura K; Okumura K; Azuma M
Eur J Immunol; 2003 Oct; 33(10):2773-82. PubMed ID: 14515261
[TBL] [Abstract][Full Text] [Related]
3. Programmed death 1 and its ligands do not limit experimental foreign antigen-induced immune complex glomerulonephritis.
Ooi JD; Li M; Kourkoutzelos K; Yagita H; Azuma M; Holdsworth SR; Kitching AR
Nephrology (Carlton); 2015 Dec; 20(12):892-8. PubMed ID: 26043977
[TBL] [Abstract][Full Text] [Related]
4. Expression of programmed death 1 ligands by murine T cells and APC.
Yamazaki T; Akiba H; Iwai H; Matsuda H; Aoki M; Tanno Y; Shin T; Tsuchiya H; Pardoll DM; Okumura K; Azuma M; Yagita H
J Immunol; 2002 Nov; 169(10):5538-45. PubMed ID: 12421930
[TBL] [Abstract][Full Text] [Related]
5. The PD-1/PD-Ls pathway and autoimmune diseases.
Dai S; Jia R; Zhang X; Fang Q; Huang L
Cell Immunol; 2014 Jul; 290(1):72-9. PubMed ID: 24908630
[TBL] [Abstract][Full Text] [Related]
6. Keratinocyte-associated B7-H1 directly regulates cutaneous effector CD8+ T cell responses.
Ritprajak P; Hashiguchi M; Tsushima F; Chalermsarp N; Azuma M
J Immunol; 2010 May; 184(9):4918-25. PubMed ID: 20363965
[TBL] [Abstract][Full Text] [Related]
7. Oral Squamous Carcinoma Cells Express B7-H1 and B7-DC Receptors in Vivo.
Groeger S; Howaldt HP; Raifer H; Gattenloehner S; Chakraborty T; Meyle J
Pathol Oncol Res; 2017 Jan; 23(1):99-110. PubMed ID: 27498988
[TBL] [Abstract][Full Text] [Related]
8. Altered availability of PD-1/PD ligands is associated with the failure to control autoimmunity in NOD mice.
Yadav D; Hill N; Yagita H; Azuma M; Sarvetnick N
Cell Immunol; 2009; 258(2):161-71. PubMed ID: 19497561
[TBL] [Abstract][Full Text] [Related]
9. B7-H1 and B7-DC receptors of oral squamous carcinoma cells are upregulated by Porphyromonas gingivalis.
Groeger S; Domann E; Gonzales JR; Chakraborty T; Meyle J
Immunobiology; 2011 Dec; 216(12):1302-10. PubMed ID: 21723642
[TBL] [Abstract][Full Text] [Related]
10. Differential binding properties of B7-H1 and B7-DC to programmed death-1.
Youngnak P; Kozono Y; Kozono H; Iwai H; Otsuki N; Jin H; Omura K; Yagita H; Pardoll DM; Chen L; Azuma M
Biochem Biophys Res Commun; 2003 Aug; 307(3):672-7. PubMed ID: 12893276
[TBL] [Abstract][Full Text] [Related]
11. Blockade of B7-H1 (programmed death ligand 1) enhances humoral immunity by positively regulating the generation of T follicular helper cells.
Hams E; McCarron MJ; Amu S; Yagita H; Azuma M; Chen L; Fallon PG
J Immunol; 2011 May; 186(10):5648-55. PubMed ID: 21490158
[TBL] [Abstract][Full Text] [Related]
12. Role of the Programmed Death-1 (PD-1) pathway in regulation of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Takizawa S; Kaneyama T; Tsugane S; Takeichi N; Yanagisawa S; Ichikawa M; Yagita H; Kim BS; Koh CS
J Neuroimmunol; 2014 Sep; 274(1-2):78-85. PubMed ID: 25027060
[TBL] [Abstract][Full Text] [Related]
13. Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction.
Wang S; Bajorath J; Flies DB; Dong H; Honjo T; Chen L
J Exp Med; 2003 May; 197(9):1083-91. PubMed ID: 12719480
[TBL] [Abstract][Full Text] [Related]
14. B7-DC (PD-L2) costimulation of CD4
Nie X; Chen W; Zhu Y; Huang B; Yu W; Wu Z; Guo S; Zhu Y; Luo L; Wang S; Chen L
Cell Mol Immunol; 2018 Oct; 15(10):888-897. PubMed ID: 28479601
[TBL] [Abstract][Full Text] [Related]
15. Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1 receptor.
Shin T; Kennedy G; Gorski K; Tsuchiya H; Koseki H; Azuma M; Yagita H; Chen L; Powell J; Pardoll D; Housseau F
J Exp Med; 2003 Jul; 198(1):31-8. PubMed ID: 12847135
[TBL] [Abstract][Full Text] [Related]
16. Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation.
Kuipers H; Muskens F; Willart M; Hijdra D; van Assema FB; Coyle AJ; Hoogsteden HC; Lambrecht BN
Eur J Immunol; 2006 Sep; 36(9):2472-82. PubMed ID: 16917960
[TBL] [Abstract][Full Text] [Related]
17. The role of programmed cell death-1 (PD-1) and its ligands in pediatric cancer.
van Dam LS; de Zwart VM; Meyer-Wentrup FA
Pediatr Blood Cancer; 2015 Feb; 62(2):190-197. PubMed ID: 25327979
[TBL] [Abstract][Full Text] [Related]
18. Human decidual macrophages suppress IFN-γ production by T cells through costimulatory B7-H1:PD-1 signaling in early pregnancy.
Sayama S; Nagamatsu T; Schust DJ; Itaoka N; Ichikawa M; Kawana K; Yamashita T; Kozuma S; Fujii T
J Reprod Immunol; 2013 Dec; 100(2):109-17. PubMed ID: 24045115
[TBL] [Abstract][Full Text] [Related]
19. A fully human monoclonal antibody targeting PD-L1 with potent anti-tumor activity.
Luan Y; Chai D; Peng J; Ma S; Wang M; Ma H; Li X; Fu S; Pan X; Wang X; Qin S; Xu T
Int Immunopharmacol; 2016 Feb; 31():248-56. PubMed ID: 26773772
[TBL] [Abstract][Full Text] [Related]
20. PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication.
Wang XF; Lei Y; Chen M; Chen CB; Ren H; Shi TD
J Viral Hepat; 2013 Apr; 20 Suppl 1():27-39. PubMed ID: 23458522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
